A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The US Federal Trade Commission filed suit Wednesday to block Edwards Lifesciences Corp. from acquiring medical device maker JenaValve Technology Inc.

The son of Troy Dean Pownell is suing Tippecanoe County Jail officials and medical staff for alleged deliberate indifference to his father's medical needs. The lawsuit claims Pownell's pleas for ...

Get the latest medical device business news, application and technology trends. DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges ...

The deal grants Edwards Lifesciences almost complete ownership of JC’s transcatheter aortic valve replacement system.

As part of the purchase, Edwards acquires JC’s J-Valve System, a transcatheter aortic valve replacement for the treatment of severe aortic regurgitation. Credit: Shutterstock / MacroEcon. Edwards ...

Edwards Lifesciences Corp. continued its recent acquisition streak with its buy of JC Medical Inc., a subsidiary of Genesis Medtech International. The sale included the intellectual property and ...

JC Medical completed enrollment in its early feasibility study (EFS) of J-Valve® TF in the United States in February 2024. Approval from FDA for JC Medical to initiate its pivotal clinical trial of ...